Navigation Links
Depression Linked to Higher Odds for Poor Leg Circulation
Date:4/20/2012

FRIDAY, April 20 (HealthDay News) -- Depressed people may be at higher risk for the debilitating circulatory condition known as peripheral artery disease (PAD), a new study suggests.

PAD is due to a narrowing of the arteries in the legs and pelvis. It was known that depression is a risk factor for the constriction of heart arteries, but its link with PAD specifically was unclear.

In this study, researchers led by Marlene Grenon of the University of California, San Francisco, Medical Center examined data on more than a thousand men and women who were followed for about seven years.

At the start of the study, PAD was present in 12 percent of the participants with depression and in 7 percent of those without depression. During the seven-year follow-up, PAD-related events occurred in 9 percent of participants with depression and in 6 percent of those without depression, the researchers said.

One expert wasn't surprised by the findings.

"The study reminds us of the importance of screening all patients for signs and symptoms of depression," said Dr. Lawrence Phillips, an assistant professor in the department of medicine at NYU Langone Medical Center in New York City. "Aggressive treatment of depression can improve modifiable risk factors and decrease the development of both coronary artery disease and peripheral artery disease," he added.

Still, Phillips said more study may be needed to clarify the relationship between depression and PAD.

"We know that there are multiple risk factors for developing PAD such as tobacco use and high blood pressure. These were not excluded in the analysis, so we cannot tell at this point if the fact the person has depression was independently associated with PAD or if the increased likelihood of PAD was from all of the other risk factors listed," he noted.

The study was to be presented Friday at an American Heart Association meeting in Chicago.

Cramping, fatigue or pain in the leg or hip muscles while walking or climbing stairs are the most common symptoms of PAD. The pain typically goes away with rest and returns when you walk again, according to information on the heart association website.

According to the heart association, high blood pressure or high cholesterol are risk factors for PAD, and people who smoke or have diabetes are at especially high risk for the condition. People with PAD also have a four to five times higher risk of heart attack or stroke.

Many people with PAD mistake the symptoms for something else and PAD often goes undiagnosed by doctors. Left untreated, the condition can even lead to gangrene and amputation, the heart association notes.

However, PAD is easily and painlessly diagnosed and most cases of PAD can be managed with lifestyle changes and medication, the experts said.

More information

The U.S. National Heart, Lung, and Blood Institute has more about peripheral artery disease.

-- Robert Preidt

SOURCE: Lawrence Phillips, M.D., assistant professor, department of medicine, NYU Langone Medical Center, New York City; American Heart Association, news release, April 20, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Use of Ecstasy, Speed by Teens Tied to Later Depression
2. Study: No link between depression, nasal obstruction
3. Speed and ecstasy associated with depression in teenagers
4. Researchers Develop Blood Test for Depression
5. Depression, Anxiety Tied to Physical Disabilities in Seniors
6. Obstructive Sleep Apnea May Be Linked to Depression
7. Stigma, Shame Can Worsen Depression in Lung Cancer Patients
8. Study Explains How Shock Therapy Might Ease Severe Depression
9. Depression Tied to Earlier Death in Heart Patients
10. Depression increases death risk in coronary stent patients
11. Hiding emotions may exacerbate depression among black men who confront racial discrimination
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Depression Linked to Higher Odds for Poor Leg Circulation
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: